GlassScriptPhysician profile
Thomas M Herrmann
NPI 1710964523
$450.60
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $48.76 · 2021: $43.25 · 2022: $185 · 2023: $21.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $130.34 | 2019-2022 | |
| Kci USA, INC. | $44.14 | 2019-2022 | |
| Linvatec Corporation | $34.79 | 2019 | |
| Stryker Corporation | $34.07 | 2019 | |
| Nabriva Therapeutics, Plc | $32.41 | 2022 | |
| Tactile Systems Technology INC | $30.75 | 2020-2022 | |
| Grt US Holding, INC. | $28.09 | 2022 | |
| Osiris Therapeutics INC. | $23.28 | 2019 | |
| Djo, LLC | $21.46 | 2023 | Cmf |
| Organogenesis INC. | $19.32 | 2019-2020 | |
| Boston Scientific Corporation | $18.88 | 2019 | |
| Acell, INC. | $17.57 | 2020 | |
| Bioventus LLC | $15.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Herrmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.